Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Benzocaine is a local anesthetic of the amino ester class used primarily as a topical agent for the temporary relief of pain and itching associated with minor burns (including sunburn), insect bites or stings, poison ivy/oak/sumac exposure, minor cuts or scratches. It is also used to numb mucous membranes during certain medical procedures. Benzocaine works by diffusing into nerve cells and binding to voltage-gated sodium channels on neuronal membranes. This action prevents sodium influx required for depolarization and propagation of nerve impulses—thereby blocking sensation in the area where it is applied[1][2][5]. Its onset is rapid but duration short (about 10 minutes). Benzocaine does not cause unconsciousness like general anesthetics[2]. It has been widely available over-the-counter in various forms such as gels/jellies/creams/ointments/liquids/sprays[2][4]. The drug carries a risk of methemoglobinemia—a rare but serious blood disorder—and should not be used in children under 2 years old due to this risk[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on benzocaine.